Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms Academic Article uri icon

Overview

MeSH Major

  • Neuroendocrine Tumors
  • Pancreatic Neoplasms

abstract

  • Grading of pancreatic neuroendocrine neoplasms on cytology may not correlate exactly with concurrent core needle biopsy, but cytology differentiation and grade are predictive of survival based on stage-adjusted analysis. Cancer Cytopathol 2017;125:188-196. © 2016 American Cancer Society.

publication date

  • March 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5352475

Digital Object Identifier (DOI)

  • 10.1002/cncy.21817

PubMed ID

  • 28094897

Additional Document Info

start page

  • 188

end page

  • 196

volume

  • 125

number

  • 3